◤ Breaking News
◤ Review the HTAi Strategic Plan
HTAi’s draft 2025–2027 Strategic Plan is now available—and we invite you to review it ahead of upcoming consultation activities.
A Strategic Plan defines an organization’s purpose, priorities, and intended impact. For HTAi, this plan is more than a roadmap, it’s a tool to remain aligned with the evolving needs of the global HTA community. Reflecting today’s fast-changing health and policy landscape, this new plan moves to a shorter, two-year cycle to allow for greater agility, responsiveness, and stakeholder engagement.
The Plan outlines five strategic pillars: Scientific Exchange, People, Capacity Building, Advocacy, and Global, each supported by an operational approach focused on convening, listening, connecting, adapting, and supporting.
Over the next three months, HTAi will host a global consultation to gather feedback. Opportunities to participate will include:
- A survey (open throughout the consultation period)
- Regional webinars across six global regions
- Engagement with key groups including the Legacy Advisory Council, Interest Group Chairs, and PFAC
Your input is essential. Follow the button below to read the draft Strategic Plan and prepare to take part in the consultation.
◤ HTAi Interest Group Steering Committee Name Update
The HTAi Interest Group Steering Committee has officially updated its name to the HTAi Interest Group Advisory Committee, a change that better reflects the group’s evolving role in guiding the strategic direction, coordination, and impact of HTAi Interest Groups.
This change also comes with a leadership update: Debjani Mueller, HTAi Vice President, has been appointed Chair of the Interest Group Advisory Committee. Her experience and insight will help strengthen connections across Interest Groups and support their contributions to HTAi’s mission.
The Advisory Committee will continue to play a key role in fostering collaboration, sharing knowledge, and ensuring Interest Groups remain aligned with the needs of our global HTA community.
Learn about HTAi Interest Groups◤ Join us in Tunis, Tunisia, for the HTAi MENA Regional Meeting!
Looking to connect with HTA leaders in the MENA region?
Join us in Tunis, Tunisia for the HTAi Middle East and North Africa (MENA) Regional Meeting, taking place September 24–25, 2025. Hosted in collaboration with INEAS, this regional event will explore practical solutions to shared challenges, enhance technical capacity, and strengthen networks across the HTA ecosystem.
The draft agenda is now live, and sponsorship opportunities are available.
Are you interested in shaping the conversation or showcasing your organization’s role in advancing HTA? Now is the time to get involved!
Visit our Regional Meeting page to view the agenda and secure your spot.
Learn more and register◤ A Look Back
◤ Congratulations to the HTAi 2025 Annual Meeting Award Recipients!
Awards
HTAi Awards recognize and celebrate excellence in HTA. We are delighted to extend our congratulations to all the outstanding award recipients celebrated at the HTAi Annual Meeting.
Egon Jonsson Award
Candidates:
- Shin S, Kim Y, Choi J, Park JY. Deliberative process of health technology reassessment by health technology assessment agency in Korea. International Journal of Technology Assessment in Health Care. 2024;40(1):e28.
- Refolo P, Duthie K, Hofmann B, Stanak M, Bertelsen N, Bloemen B, et al. Ethical challenges for Health Technology Assessment (HTA) in the evolving evidence landscape. International Journal of Technology Assessment in Health Care. 2024;40(1):e39.
- Söderholm Werkö S, Mattsson T, Tranæus S, Östlund P, Sundell K. The transition of assessing health technologies to social interventions in Sweden. International Journal of Technology Assessment in Health Care. 2024;40(1):e66.
Award recipient: Shin S, Kim Y, Choi J, Park JY. Deliberative process of health technology reassessment by health technology assessment agency in Korea. International Journal of Technology Assessment in Health Care. 2024;40(1):e28.
Top Reviewer Award
Top Reviewer Candidates:
- Carlo Lazzaro
- Deirdre DeJean
- Don Husereau.
Award Recipient: Carlo Lazzaro
Special Recognition of Editorial Board Members:
- Cliff Goodman
- Yingyao Chen
- Guy Maddern
- Varinder Jeet
- Andrew Partington
Jill Sanders Memorial Scholarship 2024 Award Recipient
Luciana Silu Mduma (Tanzania)
Sigrid Droste Ethics Award 2025 Recipient
Tier 1 Career Award — Dario Sacchini, Università Cattolica Del Sacro Cuore, Italy.
HTAi Annual Meeting Presentation Awards
- Best Oral Presentation: Awarded to Tara Schuller for “Advancing Towards Environmental Impact Assessment In Health Technology Assessment“.
- Best Student Oral Presentation: Awarded to Annapoorna Prakash for “Defining And Classifying Digital Health Technologies: A Review Of Literature And Delphi Consensus Approach”.
- Best Poster: Awarded to Carla Colaci for “Ultra-Fast Health Technology Assessments: A Descriptive Analysis Of Practices In A Latin American Agency“.
- Best Student Poster Award: Awarded to Zsófia Turk for “Assessing Medical Devices: A Qualitative Study From The Perspective Of Values In Doing Assessments Of Health Technologies (VALIDATE)”.
◤ Available on-demand— HTAi Webinar | Assessing Unmet Needs in Rare Diseases: Can the NEED Framework Enhance the HTA Process?
Did you miss our latest live webinar? You can now watch it on-demand to explore how the NEED framework can strengthen HTA of Rare Disease Therapies (RDTs) by providing a more structured lens for evaluating unmet needs.
Hear from leading experts, including:
- Alessandra Blonda, KU Leuven (Belgium)
- Irena Cleemput, KCE (Belgium)
- François Houÿez, EURORDIS (France)
- Nicole Mittmann, Canada’s Drug Agency (Canada)
- Elena Nicod, RDIG Project Group 2 Perspective (Italy)
- Vinciane Pirard, Sanofi (Belgium)
Moderated by Veronica Lopez Gusset from the HTAi Rare Diseases Interest Group, this session offers valuable insights and perspectives on advancing HTA practices in rare diseases.
Learn more◤ Network News
◤ HTAi Webinar | Health Technology Assessment for Rare Diseases in Developing Countries: Insights about Strategies to Promote a collaborative network?
Join us on August 1, 2025, at 1:00 PM CEST for an insightful webinar on HTA of Rare Diseases in developing countries.
This webinar aims to bridge insights about strategies by providing a comprehensive perspective from experts who could be instrumental for other developing countries with similar developmental trajectories.
Our focus for the webinar is particularly addressing genetic and rare conditions and the HTA challenges impacting access to services and therapies
Speakers include:
- Adriane Dias, Casa Hunter (Brazil)
- Christine Mutena, Rare Diseases Kenya (Kenya)
- Thekra Hasan Mohamed Abu Dhabi Department of Health (UAE)
- Sheela Upadhyaya, HTAi Rare Diseases Interest Group (United Kingdom)
- Duangrurdee Wattanasirichaigoon, Faculty of Medicine, Ramathibodi Hospital Perspective (Thailand)
The webinar will be moderated by Monica Ferrie, Chief Executive, Genetic Support Network of Victoria (Australia) and Steering Committee member HTA in Developing Countries Interest Group (DCIG).
Register Now◤ HTA News from Around the World
Canada’s Drug Agency invites the HTA community to save the date for its 2026 Symposium, taking place April 22, 2026 to April 24, 2026, in Ottawa, Canada. Registration will open in Winter 2025.
Read MorePAHO reflects on the RedETSA XVI Annual Meeting.
Read MoreOHE provides insight on healthcare transformation in the Middle East.
Read More◤ IJTAHC Featured Publications
Actions for Stakeholders to Develop Better Real-World Evidence for HTA/Payer Decision-Making.
Read MoreCore competencies for ethics experts in health technology assessment.
Read MoreRedefining value assessment and healthcare funding priorities for medicines: the journey to patient-centric decision making in APAC – a systematic literature review.
Read More